Mediware Acquires CPR+ Software
News Jul 24, 2013
Mediware Information Systems, Inc. announced that it has acquired Definitive Homecare Solutions, Ltd. (DHS). Widely known in the market by the name of its flagship software solution, CPR+, DHS serves home infusion, home medical equipment (HME) and retail and sub-acute specialty pharmacy organizations. Mediware acquired more than 600 new customers and the related expertise, products, services and contracts of DHS.
Mediware has operated in the home infusion, HME, home health nursing and specialty pharmacy sector since 2008, and the company plans to integrate the DHS/CPR+ business into its existing Alternate Care Solutions business line. Over the past five years, Mediware has built an expansive portfolio of homecare solutions through acquisitions, including its recent acquisition of Fastrack in June 2013.
"Market conditions are ripe for consolidation in the homecare technology sector as care shifts to home-based settings," said Thomas Mann, Mediware’s president and chief executive officer. Health reform, aging populations, prevalence of chronic disease and other factors are triggering rapid growth in homecare, increasing the need for providers to access software products and services that drive down costs, maximize safety and efficiency and support business growth.
“Mediware Alternate Care Solutions has built a solid reputation for powerful products and smart subject matter experts and acquiring DHS deepens our expertise in homecare even more,” added Mann. “DHS is a forward-thinking company that shares Mediware’s vision for delivering homecare technology with advanced functionality and interoperability. We’re very excited to welcome CPR+ to the Mediware family of solutions.”
Jeff Johnston and Stuart Crane, co-owners of DHS/CPR+ who launched the company in 1993, also view the acquisition as a significant benefit to the homecare organizations they serve. “This development gives us a lot of momentum,” Johnston said. “Stuart and I see it as a tremendous opportunity to blend our expertise together with Mediware’s to make the best software and related solutions in the homecare industry.”
An artificial intelligence (AI) approach based on deep learning convolutional neural network (CNN) could identify nuanced mammographic imaging features specific for recalled but benign (false-positive) mammograms and distinguish such mammograms from those identified as malignant or negative.
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019